DIOWELPREX ER 750

Divalproex Sodium Extended Release 750mg is a stable coordination compound of sodium valproate and valproic acid, functioning as a broad-spectrum anticonvulsant and mood-stabilizing agent. It has been a cornerstone medication in neurology and psychiatry for decades, valued for its versatility across a range of neurological and psychiatric conditions.

Under the brand name Diowelprex ER 750, manufactured by Steris Healthcare, this extended-release formulation is designed to provide smooth, sustained drug levels over 24 hours, supporting consistent seizure control, mood stabilization, and reduced pill burden through convenient once-daily dosing.

Product Information

Why It's Important

Epilepsy and bipolar disorder are among the most challenging chronic neurological and psychiatric conditions to manage, both requiring long-term, consistent pharmacological control to prevent debilitating and sometimes dangerous episodes. Uncontrolled seizures carry significant risks, including injury, status epilepticus, and profound impact on daily functioning, education, and employment. Similarly, unmanaged manic episodes in bipolar disorder can lead to severe disruption of relationships, finances, and overall quality of life.

Divalproex Sodium's broad-spectrum efficacy across multiple seizure types, combined with its well-established role in acute mania and mood-episode prevention, makes it one of the most versatile and widely prescribed agents in this therapeutic space. Its additional efficacy in migraine prophylaxis further extends its clinical relevance, offering physicians a single agent that can address overlapping neurological presentations in appropriate patients.

The extended-release formulation used in Diowelprex ER 750 carries particular clinical significance. Immediate-release valproate formulations can produce sharp peaks and troughs in blood levels, which are associated with a higher incidence of side effects such as nausea and sedation, as well as less consistent seizure or mood control. An extended-release tablet, by contrast, is specifically engineered to release the drug gradually, maintaining steadier plasma concentrations and supporting the simplified, once-daily dosing that meaningfully improves long-term adherence — a critical factor in chronic conditions like epilepsy and bipolar disorder, where missed doses can have serious clinical consequences.

The reliability of a WHO-GMP and ISO 9001:2018 certified manufacturer like Steris Healthcare is especially important for a narrow-therapeutic-index drug like divalproex sodium, where consistent release kinetics and potency batch-to-batch directly affect seizure control and mood stability for patients relying on this medication daily.

Key Benefits

What Are the Benefits of Diowelprex ER 750?

Divalproex Sodium Extended Release 750mg, as formulated in Diowelprex ER 750, offers several clinically meaningful advantages:

• Broad-spectrum anticonvulsant efficacy: Divalproex sodium is effective across multiple seizure types, including generalized, absence, and partial seizures, making it a versatile first-line or adjunctive option in epilepsy management.
• Established efficacy in bipolar disorder: Clinical evidence supports divalproex sodium's effectiveness in controlling acute manic and mixed episodes, as well as reducing the frequency of mood episode recurrence in maintenance therapy.
• Effective migraine prophylaxis: For patients with frequent or debilitating migraines, divalproex sodium has demonstrated efficacy in reducing headache frequency when used as a preventive therapy.
• Smooth, sustained drug delivery: The extended-release formulation provides steady 24-hour blood levels, reducing the peak-related side effects and fluctuating symptom control associated with immediate-release formulations.
• Convenient once-daily dosing: This simplifies long-term treatment regimens for patients managing chronic neurological or psychiatric conditions, supporting better adherence over time.
• Versatility across overlapping conditions: For patients who present with both seizure activity and mood instability, or migraine and mood symptoms, divalproex sodium can offer combined therapeutic benefit within a single medication.
• Decades of established clinical experience: Long-standing use across neurology and psychiatry has generated a well-characterized efficacy and safety profile, supporting informed treatment decisions by specialists.
• Trusted manufacturing standards: Diowelprex ER 750 is manufactured by Steris Healthcare, a WHO-GMP and ISO 9001:2018 certified pharmaceutical company, ensuring consistent potency and reliable extended-release performance across every batch — critical for a narrow-therapeutic-index medication used long-term.

Side Effects 

Common side effects associated with Divalproex Sodium Extended Release include:

• Nausea and gastrointestinal upset, particularly during treatment initiation
• Drowsiness or sedation
• Tremor
• Weight gain
• Hair thinning or hair loss
• Dizziness
• Headache
• Mild changes in menstrual cycle patterns in some women

Most mild side effects tend to improve over the first few weeks of treatment as the body adjusts, and many can be minimized through gradual dose titration guided by the prescribing physician.

Precautions & Warnings

Before starting Diowelprex ER 750, patients and prescribers should carefully consider the following precautions:

• Pregnancy: Divalproex sodium carries a significant risk of birth defects and developmental effects when used during pregnancy, particularly in the first trimester, and is generally avoided in women of childbearing potential unless no suitable alternative exists; effective contraception and specialist counseling are essential.
• Liver Disease: Should be used with extreme caution or avoided in patients with pre-existing significant hepatic impairment, given the risk of hepatotoxicity.
• Pancreatic Disease: Caution is required in patients with a history of pancreatitis.
• Bleeding Disorders: Should be used cautiously in patients with known bleeding or platelet disorders, given its potential effect on platelet count and function.
• Suicidal Thoughts: Patients and caregivers should be counseled to monitor for any new or worsening mood changes, depression, or suicidal thinking, particularly during the early months of treatment.
• Urea Cycle Disorders: Contraindicated in patients with known urea cycle enzyme deficiencies due to the risk of hyperammonemia.
• Elderly Patients: Lower starting doses and closer monitoring are generally recommended, given increased sensitivity to sedative effects.
• Drug Interactions: Caution is required when combining with other antiepileptic drugs, anticoagulants, aspirin, and certain antibiotics, due to potential interaction effects on blood levels and bleeding risk.
• Regular Monitoring: Periodic liver function tests, complete blood counts, and, where relevant, blood level monitoring are recommended throughout treatment.

Mechanism of Action 

Divalproex Sodium Extended Release 750mg exerts its therapeutic effects through several complementary mechanisms in the central nervous system:

1. Enhancement of GABAergic Activity: Divalproex sodium increases the availability of gamma-aminobutyric acid (GABA), the brain's principal inhibitory neurotransmitter, by inhibiting GABA transaminase and enhancing glutamic acid decarboxylase activity, resulting in reduced neuronal excitability.
2. Blockade of Voltage-Gated Sodium Channels: Similar to other anticonvulsants, divalproex sodium modulates voltage-dependent sodium channels, stabilizing neuronal membranes and reducing repetitive, high-frequency neuronal firing associated with seizures.
3. Modulation of T-Type Calcium Channels: This action is particularly relevant to its efficacy in absence seizures, where abnormal thalamocortical calcium channel activity plays a key role.
4. Mood-Stabilizing Effects: The precise mechanism underlying divalproex sodium's mood-stabilizing action in bipolar disorder is not fully understood but is believed to involve modulation of neuronal excitability and neurotransmitter systems implicated in mood regulation.
5. Migraine Prophylactic Action: Divalproex sodium's effect on reducing cortical neuronal excitability is thought to contribute to its efficacy in preventing migraine, potentially by reducing the susceptibility to cortical spreading depression associated with migraine pathophysiology.

This multi-mechanism action across sodium channels, calcium channels, and GABAergic neurotransmission explains divalproex sodium's broad clinical utility across epilepsy, bipolar disorder, and migraine prophylaxis — a versatility that few other single agents in neurology and psychiatry can match.

Frequently Asked Questions (FAQ)

1. Where can I buy Divalproex Sodium online?
You can purchase Divalproex Sodium through licensed online pharmacies or authorized pharmaceutical suppliers. Verify the strength, formulation, manufacturer, batch number, expiry date, and packaging before purchasing.

2. What is the price of Divalproex Sodium?
The price may vary depending on the brand, strength, formulation, pack size, manufacturer, seller, and applicable pharmacy charges. Check the current listed price before ordering.

3. Can I order Divalproex Sodium online?
Yes, Divalproex Sodium can be ordered online where legally available. It is a prescription medicine, so a valid prescription may be required. Purchase only from a licensed pharmacy or authorized supplier.

4. Is Divalproex Sodium available from Steris Healthcare?
Availability depends on Steris Healthcare's current product range and stock status. Contact Steris Healthcare or an authorized distributor to confirm availability, strength, formulation, pack size, and ordering details.

5. What is Divalproex Sodium used for?
Divalproex Sodium is used to manage certain seizure disorders and manic episodes associated with bipolar disorder. Some formulations may also be prescribed for the prevention of migraine headaches. Its use depends on the patient's condition and medical assessment.

6. What is the composition of Divalproex Sodium?
Divalproex Sodium contains Divalproex Sodium as the active pharmaceutical ingredient. The exact strength and inactive ingredients depend on the specific formulation.

7. Is a prescription required?
Yes, Divalproex Sodium should be used under the supervision of a qualified healthcare professional, and a prescription is generally required. Regular medical monitoring may be recommended during treatment.

8. How should Divalproex Sodium be taken?
Take Divalproex Sodium exactly as prescribed by your doctor. Follow the recommended dose and schedule, and swallow the formulation as directed. Do not crush or chew delayed-release or extended-release tablets unless specifically instructed.

9. What should I know before buying Divalproex Sodium?
Before buying, verify the exact strength, formulation, manufacturer, batch number, expiry date, and storage requirements. Inform your doctor about liver or pancreatic problems, bleeding disorders, pregnancy or plans for pregnancy, allergies, and all medicines or supplements you take.

10. How can I order Divalproex Sodium online?
Order Divalproex Sodium through a licensed online pharmacy or authorized pharmaceutical supplier. Provide a valid prescription, select the prescribed formulation and strength, and verify the product, storage, and delivery details before completing your purchase.